Aptose Biosciences Inc.
13F holders, Q2 2024 (June 30)23holders −2
2new positions
3sold out
$0.76avg. 13F price*
At the end of Q2 2024, 23 institutions reported holding Aptose Biosciences Inc. in their 13F filings, down 2 from Q1 2024. 2 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($1.3M), DRW Securities, LLC ($450K) and Sigma Planning Corp ($178K).
- Company
- Aptose Biosciences Inc.
- CUSIP
- 03835T309
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.3M |
| Exits | 3 | $43K |
All 13F filers, Q1 2024 → Q2 2024: 1,766,105 shares bought and 42,896 shares sold, net +1,723,209 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Armistice Capital, LLC | 0.03% | New | 1,713,000 | $1.3M |
| DRW Securities, LLC | 0.03% | No change | 592,829 | $450K |
| Sigma Planning Corp | 0.01% | Add +25.8% | 234,468 | $178K |
| Nantahala Capital Management, LLC | 0.01% | Reduce -12.7% | 77,340 | $59K |
| Morgan Stanley | 0.00% | Reduce -10.4% | 30,360 | $23K |
| Cetera Investment Advisers | 0.00% | Reduce -9.8% | 19,238 | $15K |
| Texas Capital Bank Wealth Management Services Inc | 0.00% | No change | 12,448 | $9K |
| PDS Planning, Inc | 0.00% | No change | 10,000 | $8K |
| TD Waterhouse Canada Inc. | 0.00% | Add +2.7% | 7,545 | $6K |
| ORG Partners LLC | 0.00% | New | 4,000 | $3K |
| Royal Bank of Canada | 0.00% | Add +62.6% | 2,219 | $2K |
| US Bancorp \de | 0.00% | No change | 2,020 | $2K |
| Gleason Group, Inc. | 0.00% | No change | 1,216 | $923 |
| NFSG Corp | 0.00% | No change | 832 | $631 |
| Osaic Holdings, Inc. | 0.00% | No change | 420 | $319 |
| HighMark Wealth Management LLC | 0.00% | No change | 300 | $228 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 133 | $101 |
| Group One Trading LLC | 0.00% | No change | 115 | $87 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 102 | $76 |
| Pacific Capital Wealth Advisors, Inc. | 0.00% | No change | 6 | $5 |
| FIL Ltd | 0.00% | No change | 1 | $1 |
| Citigroup Inc. | 0.00% | No change | 1 | $1 |
| National Bank of Canada | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is APTOSE BIOSCIENCES INC's weight in each manager's 13F, not the share of Aptose Biosciences Inc. the manager owns.